rs531081279
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_022051.3(EGLN1):c.319G>T(p.Ala107Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,308,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A107G) has been classified as Uncertain significance.
Frequency
Consequence
NM_022051.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EGLN1 | NM_022051.3 | c.319G>T | p.Ala107Ser | missense_variant | 1/5 | ENST00000366641.4 | NP_071334.1 | |
EGLN1 | NM_001377260.1 | c.319G>T | p.Ala107Ser | missense_variant | 1/4 | NP_001364189.1 | ||
EGLN1 | NM_001377261.1 | c.319G>T | p.Ala107Ser | missense_variant | 1/4 | NP_001364190.1 | ||
EGLN1 | XM_024447734.2 | c.319G>T | p.Ala107Ser | missense_variant | 1/3 | XP_024303502.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EGLN1 | ENST00000366641.4 | c.319G>T | p.Ala107Ser | missense_variant | 1/5 | 1 | NM_022051.3 | ENSP00000355601.3 | ||
ENSG00000287856 | ENST00000662216.1 | c.30+40868G>T | intron_variant | ENSP00000499467.1 | ||||||
ENSG00000287856 | ENST00000653908.1 | c.30+40868G>T | intron_variant | ENSP00000499669.1 | ||||||
ENSG00000287856 | ENST00000653198.1 | n.433+40902G>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151726Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000389 AC: 45AN: 1156822Hom.: 0 Cov.: 31 AF XY: 0.0000323 AC XY: 18AN XY: 557508
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151834Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74228
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.319G>T (p.A107S) alteration is located in exon 1 (coding exon 1) of the EGLN1 gene. This alteration results from a G to T substitution at nucleotide position 319, causing the alanine (A) at amino acid position 107 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Erythrocytosis, familial, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 107 of the EGLN1 protein (p.Ala107Ser). This variant is present in population databases (rs531081279, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with EGLN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 241416). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at